Heartflow, Inc. (HTFL): Operating Income

Annual figures by period end, from SEC filings.

-$64.07M

Year ended 2025-12-31

-$80.25M

Trailing 12 months to 2026-06-30

2023-12-31 Operating Income (USD) 2025-12-31

Period ended	Operating Income	Change YoY	Source filing
2025-12-31	-$64.07M	n/m	2026-03-18, From 2025-01-01
2024-12-31	-$61.22M	n/m	2026-03-18, From 2024-01-01
2023-12-31	-$72.91M	n/a	2026-03-18, From 2023-01-01

Operating Income at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Operating Income	Change YoY
Heartflow, Inc. (HTFL)	2025-12-31	-$64.07M	n/m
SI-BONE, Inc. (SIBN)	2025-12-31	-$22.33M	n/m
Neuronetics, Inc. (STIM)	2025-12-31	-$31.44M	n/m
Treace Medical Concepts, Inc. (TMCI)	2025-12-31	-$54.15M	n/m
InfuSystem Holdings, Inc (INFU)	2025-12-31	$11.92M	+73.0%
Xtant Medical Holdings, Inc. (XTNT)	2025-12-31	$7.28M	n/m
Cerus Corp (CERS)	2025-12-31	-$8.68M	n/m
Orthopediatrics Corp (KIDS)	2025-12-31	-$39.24M	n/m
Lemaitre Vascular Inc (LMAT)	2025-12-31	$67.91M	+30.0%

Compare HTFL, SIBN, STIM, TMCI side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗